| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 01/20/2005 | WO2004092390A3 Dna constructs and methods to enhance the production of commercially viable transgenic plants |
| 01/20/2005 | WO2004087952A8 Genes regulated by hydrogen peroxide stress |
| 01/20/2005 | WO2004087912A8 Inhibitor proteins of a protease and use thereof |
| 01/20/2005 | WO2004087308A8 Method of synthesis and testing of combinatorial libraries using microcapsules |
| 01/20/2005 | WO2004087207A3 Method for inducing apoptosis and aneuploidy regression in cancer cells |
| 01/20/2005 | WO2004076648A9 Clinically relevant animal model of human breast cancer and vegf involement in desmoplastic response. |
| 01/20/2005 | WO2004074442A3 Plant regulatory sequences for selective control of gene expression |
| 01/20/2005 | WO2004072250A9 Galacturonosyl transferases, nucleic acids encoding same and uses therefor |
| 01/20/2005 | WO2004072235A3 Cotton event mon 88913 and compositions and methods for detection thereof |
| 01/20/2005 | WO2004070005B1 Double ended sequencing |
| 01/20/2005 | WO2004057004A3 Plant genes and their use in controlling abcission in plants |
| 01/20/2005 | WO2004050698A3 Peptide conjugate useful for cell nucleus molecular imaging and tumor therapy |
| 01/20/2005 | WO2004048925A3 NaCT AS A TARGET FOR LIFESPAN EXPANSION AND WEIGHT REDUCTION |
| 01/20/2005 | WO2004043977A3 2’-fluoro substituted oligomeric compounds and compositions for use in gene modulations |
| 01/20/2005 | WO2004034995A3 Methods and reagents for inducing immunity |
| 01/20/2005 | WO2004024886A3 Microarray synthesis and assembly of gene-length polynucleotides |
| 01/20/2005 | WO2004024864A3 Rna-cleaving dna enzymes with altered regio- or enantioselectivity |
| 01/20/2005 | WO2004018620A3 Chitinase encoding dna molecule from cotton expressed preferentially in fibers during secondary cell wall deposition and the corresponding promoter |
| 01/20/2005 | WO2004015057A3 Mucin-immunoglobulin fusion proteins |
| 01/20/2005 | WO2003076630A8 Method of controlling ethanol production and mass production of lactic acid and transformant therefor |
| 01/20/2005 | WO2003072114A8 Vascular therapeutics |
| 01/20/2005 | WO2003068821A3 Anti-cd20 antibodies and fusion proteins thereof and methods of use |
| 01/20/2005 | WO2003066881A3 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 01/20/2005 | WO2003064688A3 Method of generation and management of unique sequences in dna production |
| 01/20/2005 | WO2003035848A9 Ibc-1 (invasive breast cancer-1), a putative oncogene amplified in breast cancer |
| 01/20/2005 | WO2002050289A8 Methods for the production of multimeric proteins, and related compositions |
| 01/20/2005 | US20050015834 Inbred corn line SE8505 |
| 01/20/2005 | US20050015833 Method for delivery of proteins to plant cells |
| 01/20/2005 | US20050015832 Coding for polyol carriers in plants or fungi in polyols with main chain of 5 to 8 carbons with 6 the ideal such as manniotol |
| 01/20/2005 | US20050015831 Transgenic monocot plant comprising recombinant nucleic acid encoding signal peptide linked to promoter which targets expression of the polypeptide to intracellular body |
| 01/20/2005 | US20050015830 transforming or transfecting using nucleotide sequence encoding fusion protein, signal peptide and polypeptide to help in binding to cell wall; |
| 01/20/2005 | US20050015829 Generating transgenic plants transformed on their plastome and being devoid of selection marker; transformation using DNA sequence |
| 01/20/2005 | US20050015828 Plants having enhanced nitrogen assimilation/metabolism |
| 01/20/2005 | US20050015827 QTL "mapping as-you-go" |
| 01/20/2005 | US20050015826 Hypoallergenic transgenic soybeans |
| 01/20/2005 | US20050015825 Method of preparing eggs for nuclear transfer and uses thereof |
| 01/20/2005 | US20050015824 Compositions for the derivation of germ cells from stem cells and methods of use thereof |
| 01/20/2005 | US20050015823 Screening methods employing fish model assessment of vision |
| 01/20/2005 | US20050015820 Using transgenic mouse tissue as model for monitoring agents that affect appetite, energy expenditure and caloric and food intake; dietetics and weight gain |
| 01/20/2005 | US20050015819 Generating animal model with enhanced tau protein expression; for use as tool in treatment and prevention of neurodegenerative diseases |
| 01/20/2005 | US20050014931 A monoclonal antibody or an antigen-binding fragment thereof that specifically binds the capsular polysaccharide of Streptococcus pneumoniae serotype PPS 3; heavy chain amino acid sequence as well as DNA encoding it; complementary determining regions; pneumonia; passive immunizations; diagnosis/medical/ |
| 01/20/2005 | US20050014834 Selective anesthetic agents and methods of identifying the same |
| 01/20/2005 | US20050014821 Compounds and methods for treating neurodegenerative disorders |
| 01/20/2005 | US20050014713 Controlling gene expression;diagnosis, therapy of disease; antidiabetic agents; insulin resistance |
| 01/20/2005 | US20050014711 Using oligonucleotide antibody |
| 01/20/2005 | US20050014710 Compositions and methods relating to prostate specific genes and proteins |
| 01/20/2005 | US20050014695 Uses of a chemokine receptor able to bind to MCP-1, MIP-1 alpha and/or rantes |
| 01/20/2005 | US20050014692 Isolate nucleic acids; intensify stimulated insulin elimination; antidiabetic agents |
| 01/20/2005 | US20050014688 Inducer of apoptosis |
| 01/20/2005 | US20050014687 Nucleoc acid sequences coding polypeptides; binding to antibodies; diagnosis, therapy of diseases such as cancer |
| 01/20/2005 | US20050014270 Expression vector comprising yarrowia regulatory sequences for use in expression of preferential heterologous nucleotide sequences |
| 01/20/2005 | US20050014269 Plants with enhanced ability to produce starch and methods for obtaining them |
| 01/20/2005 | US20050014268 Poly-(ADP-ribose) polymerase (PARP); assessing agronomical fitness of plant in vitro via seed yield; subjecting to stress then measuring electron flow in mitochondrial electron transport chain |
| 01/20/2005 | US20050014267 Expression vector comprising nucleotide sequences coding galactosidase for use in modifying fruit quality |
| 01/20/2005 | US20050014266 Transcription regulator for use in controlling vectoral expression of genes associated with conferring disease, freeze, salt resistance and drought resistant crops |
| 01/20/2005 | US20050014264 Method of introducing siRNA into adipocytes |
| 01/20/2005 | US20050014263 Materials and methods for delivery and expression of heterologous DNA in vertebrate cells |
| 01/20/2005 | US20050014262 Viral expression vector for use as heterologous gene and/or therapeutic protein delivery tools; genetic vaccine |
| 01/20/2005 | US20050014261 Chimaeric phages |
| 01/20/2005 | US20050014260 Fusion protein delivery system and uses thereof |
| 01/20/2005 | US20050014259 Nucleic acid delivery |
| 01/20/2005 | US20050014258 Methods for altering cell fate |
| 01/20/2005 | US20050014257 Modulation of C-reactive protein expression |
| 01/20/2005 | US20050014251 Production fo eukaryotic proteins and nucleic acid molecules in c. elegans |
| 01/20/2005 | US20050014246 Apparatus comprising immobilized biopolymers for use in diagnostic tools in monitoring molecular interactions ; bioreactor; high throughput assay |
| 01/20/2005 | US20050014245 Apparatus for lysing cells in a controlled manner so as to efficiently separate insoluble components from a fluid lysate containing cellular components of interest; biopolymer purification |
| 01/20/2005 | US20050014244 Mutant nucleic acid; applying to textiles; animal feeds; genetic engineering |
| 01/20/2005 | US20050014243 Method of maintaining or improving a nitrile hydratase activity |
| 01/20/2005 | US20050014242 Expression vector comprising nuclelotide sequences coding seriene protease for use as therapeutic protein in treatment of inflammatory, reproductive, epidermal and neurological tissue disorders |
| 01/20/2005 | US20050014239 Modulation of sulfate permease for photosynthetic hydrogen production |
| 01/20/2005 | US20050014238 Glycerol dehydratase for use in catalyzing the fermentation of glycerol to 1,3-propanediol in transgenic microorganism; preparing polyester fibers |
| 01/20/2005 | US20050014235 Nucleotide sequences coding glucose-6-phosphate-dehydrogenase for use in the preparation of amino acids for use in animal feeds, cosmetics and medicines |
| 01/20/2005 | US20050014234 Genes from the corynebacterium glutamicum coding for regulatory proteins |
| 01/20/2005 | US20050014231 Nucleotide sequences coding enzymatic polypeptides associated with synthesis of polyunsaturated fatty acids for use as additives in pharmaceutical and nutritional compositions |
| 01/20/2005 | US20050014230 Generating immunoglobulin specific for human lymphadenopathy viral glycoprotein 120 for use in prevention and treatment of viral diseases; immunotherapy |
| 01/20/2005 | US20050014229 Using transgenic animal to prepare osteoclastogenesis inhibitory factor (OCIF) for use in treatment of osteoporosis |
| 01/20/2005 | US20050014228 Cytokine receptor protein for use in identifying modulators which prevent hepatitis viral replication and infection; viricides |
| 01/20/2005 | US20050014227 Proteases from gram positive organisms |
| 01/20/2005 | US20050014223 Renilla GFP mutants with increased fluorescent intensity and spectral shift |
| 01/20/2005 | US20050014222 Phosphatases which activate map kinase pathways |
| 01/20/2005 | US20050014221 Heat resistant protease for use in detergents, food and textile processing |
| 01/20/2005 | US20050014220 Lectin-like domain of thrombomodulin and its therapeutic use |
| 01/20/2005 | US20050014219 Genes encoding carotenoid compounds |
| 01/20/2005 | US20050014207 Monoclonal antibody hPAM4 |
| 01/20/2005 | US20050014203 Liquid tissue preparation from histopathologically processed biological samples, tissues and cells |
| 01/20/2005 | US20050014199 Mammalian cytokines; receptors; related reagents and methods |
| 01/20/2005 | US20050014192 Methods and compositions for amplification of RNA sequences |
| 01/20/2005 | US20050014190 Biallelic markers derived from genomic regions carrying genes involved in arachidonic acid metabolism |
| 01/20/2005 | US20050014188 Isolated human dehydrogenases, nucleic acid molecules encoding these human dehydrogenases, and uses thereof |
| 01/20/2005 | US20050014187 Novel polypeptide hormone phosphatonin |
| 01/20/2005 | US20050014174 Method for the detection of nucleic acids |
| 01/20/2005 | US20050014172 RNA interference mediated inhibition of muscarinic cholinergic receptor gene expression using short interfering nucleic acid (siNA) |
| 01/20/2005 | US20050014169 Nuclease inhibitor cocktail |
| 01/20/2005 | US20050014167 Anterior gradient 2 homolog (AGR2) for use as to in identifying modulator for treatment of asthma, chronic obstructive pulmonary disease (COPD), cystic fibrosis, vision defects, inflammatory bowel and cell proliferative disorders |
| 01/20/2005 | US20050014166 Compositions and systems for the regulation of genes |
| 01/20/2005 | US20050014164 Triplex-forming oligonucleotides containing modified purines and their applications |
| 01/20/2005 | US20050014154 Using nucleic acid microarrays to identify, classify and characterize bacteria associated with periodontitis; oral disease diagnosis |
| 01/20/2005 | US20050014152 Drug transporter and use thereof |
| 01/20/2005 | US20050014150 Screening eukaryotic messenger RNA sequences and identifying internal ribosome entry site (IRES) elements for use in cap-independent expression of foreign genes in eukaryotic cells; enhancing in vitro translation heterologous |
| 01/20/2005 | US20050014148 Compositions and methods relating to ovary specific genes and proteins |